Outset Medical, Inc. Sustainability Profile
Outset Medical, Inc., a pioneering force in the healthcare technology sector, is headquartered in the United States. Founded in 2010, the company has rapidly established itself as a leader in the development of innovative dialysis solutions, particularly with its flagship product, the Tablo® System. This unique device simplifies the dialysis process, making it more accessible and efficient for patients and healthcare providers alike. With a focus on transforming the dialysis experience, Outset Medical operates primarily in the renal care industry, serving hospitals and clinics across major operational regions in the US. The company has achieved significant milestones, including FDA clearance for its products, positioning itself as a key player in the market. Outset Medical's commitment to enhancing patient care through advanced technology underscores its reputation as a trusted name in the field of medical devices.
DitchCarbon Score
How does Outset Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Outset Medical, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Outset Medical, Inc.'s reported carbon emissions
Outset Medical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As a result, there is no information on their scope of emissions (Scope 1, 2, or 3) or any significant achievements in reducing carbon emissions. Without specific data or commitments, it is unclear how Outset Medical, Inc. is addressing climate change or its carbon footprint within the industry context.
How Carbon Intensive is Outset Medical, Inc.'s Industry?
How Carbon Intensive is Outset Medical, Inc.'s Location?
Outset Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Outset Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
